Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trialYi‐Long Wu, Tony Mok, Fumito Tsuji et al.|The Lancet Oncology|2017Cited by 1.2k
Identification of a novel WNK1–ROS1 fusion in a lung adenocarcinoma sensitive to crizotinibYutao Liu, Rui Lin, Tianfeng Liu et al.|Lung Cancer|2018Cited by 30
Extracellular Vesicle Clicking on Osteoimplants Through Biomimetic Molecular Adhesion Enables Immune‐Enhanced Osseointegration in DiabeticsGaoran Ge, Dechun Geng, Guoqing Pan et al.|Advanced Functional Materials|2024Cited by 23